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Dissociated Insulinotropic Sensitivity to Glucose and Carbachol in High-Fat 
Diet - Induced Insulin Resistance in C57BL/6J Mice 
Bo Ahren, Erik Simonsson, Anton J.W. Scheurink, Hindrik Mulder, Ulrika Myrs~n, and Frank Sundler 
To study islet function following reduced insulin sensitivity, we examined mice of the C57BL/6J strain, the genotype of which 
carries an increased propensity to develop insulin resistance when metabolically challenged. The mice received either a 
high-fat diet (58% fat on an energy basis) or a control diet (11% fat) for 12 weeks. The body weight of mice on the high-fat diet 
increased significantly more than that of mice on the control diet [25,8 -+ 0.4 v21.3 _+ 0.2 g, P < .001). Already after 1 week on 
the high-fat diet, a significant hyperglycemia accompanied by hyperinsulinemia had evolved, indicative of insulin resistance. 
After 12 weeks, plasma glucose levels for high-fat diet-treated mice were 7.5 _+ 0.1 mmol/L, versus 6.5 -+ 0.1 mmol/L in 
controls (P < .001); corresponding values for plasma insulin were 248 _+ 17 and 104 -+ 7 pmol/L, respectively (P < .001). Mice 
given a high-fat diet also had elevated levels of total cholesterol, triglycerides, and free fatty acids (FFAs) compared with 
controls. After 4, 8, and 12 weeks, glucose (2.8, 8.3, or 16.7 mmol/kg) or the cholinergic agonist carbachol (0.16 or 0.53 
i~mol/kg) was injected intraperitoneally. The insulinotropic response to glucose was not different between the two groups 
after 4 or 8 weeks, whereas after 12 weeks, glucose-induced insulin secretion was markedly impaired in high-fat diet-treated 
mice (P < .001), In contrast, after 8 and 12 weeks on a high-fat diet, carbachol-stimulated insulin secretion was potentiated 
(P < .01), whereas carbachol-stimulated glucagon secretion was not significantly altered. Furthermore, after 12 weeks on the 
high-fat diet, insulin secretion from isolated islets was impaired at glucose levels of 8.3, 11.1, and 16.7 mmol/L (P--- .05). 
Moreover, islet morphology as examined by immunocytochemistry using insulin antibodies and islet innervation, as revealed 
by immunostaining of tyrosine hydroxylase (TH), neuropeptide Y (NPY), galanin, vasoactive intestinal polypeptide (VIP), and 
substance P (SP) were unaffected by the high-fat diet for 12 weeks. However, quantitative in situ hybridization showed a 
3.5-fold upregulation of insulin gene expression in response to the high-fat diet (P < .001 ) despite unaltered B-cell mass and 
pancreatic insulin content. We conclude that as little as 1 week of treatment with a high-fat diet induces insulin resistance in 
C57BL/6J mice. This is accompanied later by hyperlipemia, potentiated carbachol-stimulated insulin secretion, and increased 
insulin gene expression but impaired glucose-stimulated insulin secretion. We suggest that after several weeks' duration, 
insulin resistance is accompanied by enhanced islet sensitivity to cholinergic activation and exaggerated insulin gene 
expression, whereas the failing islet sensitivity to glucose represents decompensation. 
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I NSULIN RESISTANCE is compensated for by increased insulin secretion. 1-3 The mechanism of the islet compensa- 
tion might involve a slight but continuous hyperglycemia. 
which stimulates basal insulin secretion and potentiates non-  
glucose-stimulated insulin secretion, as inferred from studies in 
humans. 1,2,4 The mechanism might also involve cholinergic 
hyperactivity, as indicated by studies in the glucose-infused rat. 
in which the potentiated glucose-stimulated insulin secretion 
was inhibited by atropine, s and in the insulin-resistant obese 
mouse, in which atropine reduced hyperinsulinemia. 6 Similarly, 
the frequency of diabetes induced by low-dose alloxan in mice 
has been shown to be increased by muscarinic blockade. 7 and 
the insulin secretory response to muscarlnic activation by 
bethanechol has been shown to be exaggerated in the obese 
mouse. 8 Following long-standing insulin resistance, this com- 
pensation in islet function might fail. resulting in a decompen- 
sated state precipitating non-insulin-dependent diabetes melli- 
tus. However. the islet consequences of long-standing insulin 
resistance are not established. To increase our understanding of 
the islet consequences of long-standing insulin resistance, we 
examined the C57BL/6J strain of mice. the genetic background 
of which carries a phenotype characterized by a high occurrence 
of insulin resistance When metabolically challenged. 9,1° It has. 
for instance, been demonstrated that when C57BL/6J mice are 
fed a high-fat diet. severe insulin resistance with hyperinsulin- 
emia develops, in contrast to Only a marginal hyperinsulinemia 
in another strain, the A/J mouse, given the same high-fat diet. 11 
Furthermore. 4 months of treatment of C57BL/6J mice with a 
high-fat diet has been shown to induce hyperglycemia, hyperin- 
sulinemia. Slight obesity, and an impaired insulin secretory 
response to glucose." 13 
In the present study, we frequently examined islet function in 
C57BL/6J mice during 12 weeks of treatment with a high-fat 
diet. We studied insulin secretion in vivo and in vitro, and 
examined islets from C57BL/6J mice using immunocytochem- 
istry and quantitative in situ hybridization for assessment of 
islet morphology and insulin gene expression. We paid particu- 
lar attention to a potential difference in the islet response to 
glucose versus the cholinergic agonisc carbachol, in line with 
the hypothesis that cholinergic supersensitivity is a mechanism 
underlying the islet adaptation to an increased requirement for 
insulin that accompanies insulin resistance. 5-8 
MATERIALS AND METHODS 
Animals 
A total of 264 female mice of the C57BL/6J strain were obtained 
from Bomholtgaard Breeding and Research Centre (Ry, Denmark) at 4 
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Table 1. Characteristics of Antisera Used in the Study 






Galanin RAGS 5777 
Human proinsulin Guinea pig 1:2,560. 
Protein-conjugated synthetic rat NPY Rabbit 1:640 
Unconjugated porcine VIP Rabbit 1:640 
U nconjugated rat TH Rabbit li320 
Protein-conjugated synthetic bovine SP Rabbit 1:320 
Unconjugated porcine galanin Rabbit 1:640 
EuroDiagnostica (Maim6, Sweden) 
EuroDiagnostica 
EuroDiagnostica 
Pel-freez Biologicals (Rogers, AR) 
Dr P.C. Emson, MRC (Cambridge, UK) 
Dr B.E. Dunning, Sandoz (E Hanover, N J) 
weeks of age. They were studied in batches of 50 to 55 mice each. At 
day 4 after arrival, half the mice in each batch started a high-fat diet 
(Research Diets, New Brunswick, NJ), and the other half received a 
standard rodent chow diet (Lactami n, Stockholm, Sweden). On a caloric 
basis, the high-fat diet consisted of 16.4% protein, 25.6% carbohY- 
drates, and 58.0% fat (total, 23.4 kJ/g), whereas the control diet 
consisted of 25.8% protein, 62.8% carbohydrates, and 11.4% fat (total, 
12.6 kJ/g). Throughout the study period of 12 weeks, the mice had free 
access to food and water. Four to five mice were kept per cage in a 
temperature-controlled (22°_  + I°C) room with a 12-hour light-dark 
cycle with lights on at 6:00 AM. The study was approved by the Animal 
Ethics Committee at Lund University. 
Baseline Parameters 
At day 4 after arrival, ie, when treatment with the various diets 
startedl and then once every week for the study period of 12 weeks, all 
animals and food consumption were weighed, and a blood sample was 
taken from the intraorbital, retrobulbar plexus for measurement of
plasma levels of insulin and glucose. 
In Vivo Experiments 
After 4, 8, and 12 weeks of treatment with a high-fat/c0ntrol diet, all 
mice underwent one in vivo study. The animals were injected intraperi- 
toneally with D-glucose (Sigma Chemical, St Louis, MO) at a dose level 
of 2.8, 8.3, or 16.7 mmol/kg, with the cholinergic agonist carbachol 
(Sigma) at a dose level of 0.16 or 0.53 gmol/kg or saline. The volume 
load was 10 taL/g body weight. Blood samples were taken at 6 and 10 
minutes after the respective injection; initial exper!ments showed that 
peak levels of plasma insulin after intraperitoneal injection Of glucose or 
carbachol in this strain of mice Occurred within this period (data not 
shown). The samples were immediately centrifuged, and the plasma 
was stored at -20°C until assayed. The mean plasma levels of glucose, 
insulin, and glucagon were calculated for the 6- and 10-minute values, 
and the mean value obtained in the control saline-injected group in the 
same series was subtracted from the mean 6- to 10-minute value 
obtained in each experimental nimal. 
In Vitro Experiments 
After 4, 8, and 12 weeks of treatment with a high-fat or control diet, 
pancreatic islets were isolated from four mice in each batch with a 
collagenase isolation technique modified from the study by Lacy and 
Kostianovsky. 14In brief, the pancreas was retrogradely filled with 3 mL 
Hanks balanced salt solution (Sigma) supplemented with 0.3 mg/mL 
Collagenase P (activity, 1.86 U/mg; Boehringer, Mannheim, Germany). 
The pancreas was subsequently removed and incubated in the same 
solution for 20 minutes at 37°C. After rinsing, the islets were 
handpicked under a stereomicroscope and incubated overnight in RPMI 
1640 medium supplemented with 10% fetal calf serum, 2.05 mmol/L 
L-glutamine, 2.5 gg/mL amphotericin B (GIBCO BRL, Paisley, Scot- 
land), 100 IU/mL penicillin, and 100 gg/mL streptomycin (Biol Ind, 
Beit Haemek, Israel) at 37°C in humidified air equilibrated with 5% 
CO2. Following overnight incubatio n, the islets were washed three 
times and then preincubated for 60 minutes at 37°C in a HEPES 
medium (pH 7.36) supplemented with 0.1% human serum albumin 
(Sigma) and 3.3 mmol/L glucose. The medium consisted of the 
following (in mmol/L): 125 NaC1, 5.9 KC1, 1.2 MgC12, 1.28 CaC12 (all 
Sigma), and 25 HEPES (Boehringer). After the preincubation, groups of 
three islets were transferred toseparate chambers containing 200 pL of 
the medium supplemented with glucose at various concentrations: 
Following incubation at 37°C for 60 minutes, 25 pL of the medium was 
collected from each chamber and stored at -20°C until analysis. 
Pancreatic Insulin Extraction 
For analysis of pancreatic insulin, approximately 50 mg of the 
Pancreas was removed from each animal and weighed. The tissue was 
thereafter homogenized in acid ethanol (0.18 mol/L HC1 in 95% 
ethanol) followed by radioimmunoassay for insulin. 
Analysis of Insulin, Glucagon, and Glucose 
Insulin in plasma, medium, and extracted tissue was determined 
radioimmunochemically is with a guinea pig anti-rat insulin antibody, 
~2SI-labeled porcine insulin as tracer, and rat insulin as standard (Linco 
Research, St Louis, MO). Free and bound radioactivity was separated 
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Fig 1. Body weight during treatment of C57BL/6J mice with a 
high-fat diet (0)  or control diet (©) for a 12-week period. At initiation 
of the study, mice were 4 weeks old. The mean -+ SEM is shown. The 
number of animals at each time point and group was 91 and 132. The 
difference between the 2 groups was highly significant (P < .001) at 
all time points from week I and onward. 
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Fig 2. Daily food intake, expressed as total amount of food intake (A) 
and daily energy intake per g body weight (B) in C57BL/6J mice given 
a high-fat diet (0)  or control diet (C)) for 12 weeks, starting at age 4 
weeks. The mean -+ SEM is showm The number of animals at each 
time point and group was 91 and 132. There was a highly significant 
difference (P < .001) between the 2 groups of mice at all time points. 
by use of an anti-IgG (goat anti-guinea pig) antibody (Linco). The 
sensitivity of the assay is 12 pmol/L, and the coefficient of variation is 
less than 7% at both low and high levels. Analyses of glucagon 
concentrations were performed on unextracted plasma 16 with a double- 
antibody radioimmunoassay using guinea pig antiglucagon antibodies 
specific for pancreatic glucagon, 125I-glucagon as tracer, and glucagon 
standard (Linco). The sensitivity of the assay is 7.5 pg/mL, and the 
coefficient of variation is less than 9% at both low and high levels. 
Plasma glucose was determined by the glucose oxidase method. 17 
Analysis of Cholesterol, Triglycerides, and Free Fatty Acids 
At 6 weeks after the start of treatment with a high-fat or control diet, 
blood was collected and plasma separated for determination of total 
cholesterol, triglycerides, and free fatty acids (FFAs). Total cholesterol 
level was measured enzymatically, 18 and triglycerides and FFAs were 
determined colorimetrically.W,2° 
Immunocytochemistry 
After 12 weeks of treatment with a high-fat or control diet, pancreatic 
specimens were removed and fixed overnight by immersion in Stefani- 
ni's solution (2% paraformaldehyde and 1.5% saturated solution of 
picric acid in 0.1 mol/L phosphate-buffered saline, pH 7.2). After 
rinsing in sucrose-enriched (10%) buffer, the specimens were frozen on 
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Fig 3. Baseline plasma levels of insulin (A) and glucose (B} during 
treatment of C57BL/6J mice with a high-fat diet (0)  or control diet 
(©) for a 12-week period. At initiation of the study, mice were 4 weeks 
old. The mean _+ SEM is shown. The number of animals at each time 
point and group was 91 and 132. The difference between the 2 groups 
was highly significant (P < .001} for both plasma insulin and plasma 
glucose at all time points from week I and onward. 
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Fig 4. Plasma levels of cholesterol, triglycerides, and FFA after 6 
weeks of treatment of C57BL/6J mice with a control diet (1~) or 
high-fat diet (IB). The mean -+ SEM is shown. There were 20 to 25 
animals per group. Random difference between groups, ***P  < ,001. 
on chromalum-coated slides. The sections were then processed for 
immunocytochemical detection of insulin, neuropeptide Y (NPY), 
vasoactive intestinal polypeptide (VIP), tyrosine hydroxylase (TH), 
galanin, and substance P (SP) using the indirect immunofluorescence 
technique. 21Details of the antisera re shown in Table 1. Fluorescein 
isothiocyanate-labeled porcine antisera gainst rabbit or guinea pig IgG 
were used as secondary antisera (dilution 1:80; EuroDiagnostica, 
Malta6, Sweden). Control sections were incubated with the antisera (in 
working dilution) preabsorbed with the respective antigen in excess 
(obtained from Peninsula Europe, Merseyside, England; 10 to 100 
lag/mL). The relative frequency of peptide-containing nerve fibers was 
assessed semiquantitatively by two independent observers. The final 
score was the mean of these stimations, and was graded as follows: 0, 
no fibers; 1, occasional nerve fibers; 2, moderate number of nerve fibers; 
and 3, numerous nerve fibers. At least seven sections were examined for 
each type of nerve fiber (NPY, VIR TH, galanin, and SR respectively). 
In Situ Hybridization 
Insulin mRNA was detected in situ in islets using a mix of 
oligonucleotide probes complementary to rat insulin mRNA I and II 
(BPR 236; R&D Systems, Abingdon, Oxon, UK); the probes were 
3'-end-tailed with 35S as previously described. 22The protocol for in situ 
hybridization has previously been described in detail. 22 Briefly, the 
pancreatic sections (5 bun thickness) were deparaffmized, rehydrated, 
and permeabilized in 0.01% Triton X-100. Before hybridization, the 
sections were treated with proteinase K (10 lag/mL; Sigma) and 
acetylated by 0.25% acetic anhydride in 0.1 mol/L triethanolamine. 
Hybridization was performed overnight at 37°C in sealed moisturizing 
chambers, using a probe concentration of 200 fmol/mL. Following 
stringent posthybridization washing, the slides were dipped in Ilford 
K-5 emulsion (Ilford Anitec, G6teborg, Sweden), exposed for 7 days, 
and developed in Kodak D-19 (Kodak, Stockholm, Sweden). Levels of 
insulin mRNA were determined by quantification of probe labeling of 
islets, using Q 500 MC Leica (Leica Cambridge, Cambridge, UK) as 
previously described in detail. 23 Briefly, before analysis, the system was 
calibrated by conversion of the grey values in a standard section to 
optical density (OD), yielding an arbitrary scale from 0 to 5. The 
calibration and illumination of the sections in the microscope were 
checked repeatedly during analysis to ensure that mRNA levels were 
determined under identical conditions. Dark-field images of islets were 
captured and digitized, and the polarity was reversed. The outline of the 
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Fig 5. Glucose-stimulated insulin secretion in vivo at 4, 8, and 12 
weeks after start of treatment with a high-fat diet (0 )  or control diet 
(©) in C57BL/6J mice as a function of plasma glucose levels. Glucose 
was injected at 2.8, 8.3, or 16.7 mmol/kg, and plasma was sampled 
after 6 and 10 minutes. The mean -+ SEIVI is shown. There were 12 to 
24 animals per group. 
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Fig 6. Carbachol-stimulated insulin secretin in vivo at 4, 8, and 12 
weeks after start of treatment with a control diet (1~) or high-fat diet 
( I )  in C57BL/6J mice. Carbachol was injected at 0.16 or 0.53 
~mol/kg, and plasma was sampled after 6 and 10 minutes. The 
mean -+ SEM is shown. There were 14 to 16 animals per group. **P  < 
.01, ***P< .001. 
Table 2. Plasma Glucagon Levels After Intraperitoneal Injection of 
Carbachol or Saline in C57BL/6J Mice Given a High-Fat or Control 
Diet for 4, 8, or 12 Weeks 
Carbachol 
Diet 0.16 Fmol/kg 0.53 Fmol/kg Saline 
4 weeks 
High-fat 98 ± 17 (15) 196 ± 9 (8) 48 ± 6 (29) 
P NS NS .005 
Control 92 -+ 8 (16) 196 -+ 29 (8) 26 -+ 2 (21) 
8 weeks 
High-fat 115 + 10 (14) 164 _+ 26 (7) 59 ± 7 (27) 
P NS NS .006 
Control 121 _+ 14 (13) 167 _+ 25 (6) 36 ± 4 (15) 
12 weeks 
High-fat 273 _+ 54 (15) 261 _+ 23 (23) 63 _+ 4 (43) 
P NS NS NS 
Control 294 ± 67 (12) 269 -- 20 (21) 59 +_ 3 (37) 
NOTE. Values are the mean ± SEM for the 6- and 10-minute plasma 
samples. Carbachol was injected at either of 2 dose levels, and 
samples were taken 6 and 10 minutes after injection. Number of 
animals is in parentheses. 
mean OD within the islets was determined, correlating with the amount 
of probe hybridized to an islet and thus to the insulin mRNA abundancy. 
In addition, the total area of insulin probe-labeled cells in the islets was 
determined, thereby ielding data on B-cell mass. Sections from each 
individual animal were analyzed in duplicate; 10 randomly selected 
islets from different parts of the sections were analyzed. 
Statistics 
The mean ± SEM are reported. Statistical comparisons for differ- 
ences between mice treated with a high-fat or control diet in body 
weight, food intake, and baseline plasma levels of insulin, glucose, and 
lipids were performed by Student's t test. Differences with regard to 
insulin, glucagon, or glucose responses toglucose or carbachol in vivo 
or to insulin secretion i  vitro were evaluated by two-way ANOVA and 
the Newman-Keul post hoc test. Insulin mRNA levels, areas of insulin 
probe-labeled cells, insulin cell numbers, and the relative frequency of 




Already after 1 week of treatment with the high-fat diet, body 
weight was significantly higher compared with control levels 
(18.0 _+ 0.1 v 16.8 _+ 0.1 g, P < .001; Fig 1). After 12 weeks, 
body weight in mice given the high-fat diet was 25.8 _+ 0.4 g 
(n = 109), versus 21.3 + 0.2 g in controls (n = 91, P < .001). 
Food Intake 
Daily food intake was stable in the two groups of mice 
throughout the study (Fig 2). Daily energy intake was slightly 
but significantly higher in mice given the high-fat diet than in 
controls (Fig 2; P < .01 between groups at all time points). 
Baseline Glucose and Insulin 
After 1 week on the high-fat diet, hyperinsulinemia was seen 
that persisted throughout he study period (Fig 3). After 12 
weeks of treatment, plasma insulin levels in mice given the 
high-fat diet were 248 _+ 17 pmol/L (n = 109), versus 104 _+ 7 
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Fig 7. Glucose-stimulated insulin secretion from islets isolated from 
C57BL/6J mice after 4, 8, or 12 weeks of treatment with a high-fat diet 
(O) or control diet (O) after incubation for 60 minutes in different 
concentrations of glucose. The medium glucose concentration is 
shown on the x-axis, and the medium insulin secretion is shown on 
the y-axis. The mean -+ SEM is shown. For each separate group and 
time, 3 to 4 different experiments with a total of 13 to 29 observations 
at each point are shown. 
pmol/L in control mice (n = 91, P < .001). Also, plasma 
glucose levels were increased after 1 week of treatment with the 
high-fat diet; this difference of approximately 1 mmol/L was 
present hroughout the study period. After 12 weeks, plasma 
glucose levels in mice given the high-fat diet were 7.5 _+ 0.1 
mmol/L (n = 109), versus 6.5 -+ 0.1 mmol/L in controls 
(n = 91, P < .001; Fig 3). 
Plasma Lipids 
After 6 weeks of treatment with the high-fat diet, plasma 
levels of cholesterol, triglycerides, and FFAs were all signifi- 
candy elevated compared with levels in mice given the control 
diet (Fig 4). 
Glucose-Stimulated Insulin Secretion In Vivo 
At 4 and 8 weeks after starting the high-fat or control diet, 
glucose-stimulated insulin secretion was not different between 
the two groups of animals (Fig 5). However, after 12 weeks of 
treatment, he plasma insulin response to glucose injected at 
16.7 mmol/kg was impaired after the high-fat diet, since it was 
446 -+ 56 pmol/L in control animals (n = 14), versus only 
203 + 62 pmol/L in animals given the high-fat diet (n = 15, 
P = .008; Fig 5). 
Carbachol-Stimulated Insulin and Glucagon Secretion In Vivo 
After 4 weeks of treatment with the two diets, there was no 
significant difference between the two groups with regard to 
carbachol-stimulated insulin secretion (Fig 6). However, after 
both 8 and 12 weeks of treatment, carbachol-stimulated insulin 
secretion was exaggerated in mice given the high-fat diet 
compared with the control diet (Fig 6). Thus, after 12 weeks of 
treatment, carbachol at 0.53 ~tmol/kg increased plasma insulin 
by 3,105 -+ 308 pmol/L in mice given the high-fat diet, versus 
an increase of only 1,544 _+ 256 pmol/L in controls (P = .002). 
In contrast, carbachol-stimulated glucagon secretion did not 
differ significantly between the two groups at any of the studied 
time points (Table 2). 
Glucose-Stimulated Insulin Secretion In Vitro 
After 4 and 8 weeks of treatment, no significant difference 
was evident between the two groups regarding glucose- 
stimulated insulin secretion in vitro (Fig 7). However, after 12 
weeks of treatment, glucose-stimulated insulin secretion was 
markedly impaired in mice given the high-fat diet, since the 
medium insulin concentration was lower after incubation of 
islets from these animals at glucose concentrations of 8.3 
mmol/L (P = .038), 11.1 mmollL (P = .021), and 16.7 mmol/L 
(P < .001). 
Cellular Expression of Insulin 
No visible difference was observed between the two groups 
of mice with regard to insulin-like immunofluorescence, as 
illustrated in representative islets from mice given the control or 
high-fat diet for 12 weeks (Fig 8). Similarly, pancreatic insulin 
content after 12 weeks of treatment did not differ between the 
groups (4.0 _+ 1.1  pmol/mg wet weight in pancreas from 
high-fat diet-treated mice, n = 6, v 3.9 _+ 0.8 in controls, 
n = 6, NS). 
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Fig 8. Immunofluorescencefor in- 
sulin in pancreatic islets from 
C57BL/6J mice given a control diet 
(A) or high-fat diet (B) for 12 weeks. 
No difference in the pattern of 
immunostaining was observed be- 
tween groups (bar = 20 i~m), 
Insulin Gene Expression 
Figure 9 illustrates representative in situ hybridizations of 
islets from the two groups of mice, hybridized with oligonucleo- 
tides complementary to proinsulin mRNA. Insulin gene expres- 
sion was markedly increased after the high-fat diet. Quantitative 
in situ hybridization showed that insulin probe labeling was 
increased approximately 3.5-fold in mice given the high-fat diet 
for 12 weeks compared with the controls (Fig 10; P < .001). In 
contrast, B-cell mass, as shown by the total area of the insulin 
probe-labeled cells, was not different between the groups: 
14,516 + 1,862 gm 2 in mice given the high-fat diet (n = 61 
islets from nine animals) compared with 14,656 _+ 1,653 gm 2 in 
controls (n = 60 islets from eight animals, NS). 
Neural Expression f lslet Neuropeptides 
Pancreatic tissues from control and high-fat diet-treated mice 
were immunostained for markers of islet nerves. Figure 11 
shows representative isl t immunostaining in the two groups of 
mice for two different neuropeptides: NPY, a marker for 
pancreatic adrenergic nerves, and VIP, a marker for pancreatic 
parasympathetic, presumably cholinergic, nerves. 24 In both 
groups of mice, islet innervation with nerves harboring these 
two neuropeptides was evident. However, there was no differ- 
ence in the relative frequency of innervati°n with NPY and VIP 
fibers between the two groups of mice (Fig 12). Furthermore, in
both groups of mice, islet innervation with nerves immunoreac- 
tive for TH and galanin (neuropeptide in pancreatic adrenergic 
nerves 24) and SP (marker for sensory nerves 25) was evident. 
However, similarly as for NPY and VIE there was no difference 
in the relative frequency of TH, galanin, and SP fibers between 
the two groups. 
DISCUSSION 
In this study, we confirm previous reports by Surwit et a111,12 
that a high-fat diet increases body weight and induces insulin 
resistance in mice of the C57BL/6J strain, as evident by slight 
hyperglycemia and marked hyperinsulinemia already after 1 
week. We also found that this insulin resistance was accompa- 
nied later (12 weeks) by impaired glucose-stimulated insulin 
secretion, which enforces the idea that this strain of mice carries 
a genetic predisposition t  develop type II diabetes mellitus. 11 
We focused our interest on the first 12 weeks of treatment with a 
high-fat diet to establish the consequences for the islet adapta- 
tion of reduced insulin resistance after several weeks, but before 
diabetes evolves. 
Reduced insulin sensitivity is compensated for by hyperinsu- 
linemia to avoid hyperglycemia. 1-3Previous studies in the 
glucose-infused rat and the ob/ob mouse have suggested that 
increased sensitivity to cholinergic activation might be a 
mechanism underlying the compensatory hyperinsulinemia. 5 8
Thus, in the ob/ob mouse, muscarinic blockade by atropine 
reduces plasma insulin levels, 6and similarly, ob/ob mice exhibit 
an increased insulinotropic action of the muscarinic agonist 
bethanechol. 8 Cholinergic activation by means of vagal nerve 
activation or administration of muscarinic agonists is known to 
stimulate insulin secretion .8,26-28 Increased vagal activity or 
muscarinic sensitivity as a compensatory esponse to peripheral 
insulin resistance would therefore increase insulin secretion. We 
Fig 9, In situ hybridization with 
radiolabe!ed insulin probes in is- 
lets from C57BL/6J mice given a 
control diet (A) or high-fat diet (B) 
for 12 weeks. The high-fat diet 
markedly increased the abun- 
dance Of insulin mRNA (bar = 
50 I~m). 
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Proinsulin mRNA levels in pancreatic islets from C57BL/6J Fig 10. 
mice given a control diet (D} or high-fat diet (11) for 12 weeks, as 
determined by quantitative in situ hybridization and shown as OD. 
The mean -+ SEM from analysis of 60 to 61 islets from 9 to 11 animals 
per group is shown. ***Random difference between groups, P < 
.001. 
examined this by Challenging the mice with the ch91inergic 
agonist carbachol at 4, 8, and 12 weeks after the start of a 
high-fat diet. We found an increased insulinotropic respons e to 
the cholinergic agonist carbachol after 8 weeks of treatment 
with the high-fat diet. This result suggests hat increased 
muscarinic activity develops a a compensation for insulin 
resistance. Increased B-cell ch01inergic •sensitivity m ght here- 
fore be of importance for maintenance of long-term hyperinsu- 
linemia. Vagal nerve activation and muscarinic agonism also 
stimulate glucagon secretion. 28,29 However, in contrast to he 
potentiated insulinotropic action of carbachol in high-fat diet- 
treated mice, the glucagon0troplc effect of carbachol was found 
not to be augmented after treatment with a high-fat diet. This 
shows that the increased sensitivity to muscarinic activation is
restricted to insulin secretion, rather than being an unspecific 
hyperactivity in the vagal system. 
In contrast o the exaggerated insulinotropic response tO 
cholinergic stimtdation, C57BL/6J mice given a hlgh-fat diet 
developed impaired glucose-stimulated insulin sec/etion under 
both in vivo and in vitro condit!ons after 12 weeks of treatment. 
This shows that tlae marke dhyperinsulinemia at this stage is not 
dependent on a potentiated insulinotropic response to glucose. 
Further, the hyperinsulinemia is not caused by islet hypertrophy, 
since B-cell mass was not altered by the high-fat diet Moreover, 
mite given the high-fat diet ha d increased insulin mRNA leve!s 
despite the •unaffected B-cell mass and Pancreatic insulin 
content. This indicates that the insulin biosynthetic machinery is 
Fig i l .  Immunofluorescence for 
NPY (aand c) or VIP (b and d) ifi 
pancreatic islets from C57BL/6J 
mice given .a control diet (a and 
b) or high-fat diet (c and d) for 12 
weeks. No difference in the pat- 
tern or degree of immunostain- 
ing Was observed' between 
groups. ( × 80.) 
ISLET ADAPTATION TO INSULIN RESISTANCE IN MICE 105 
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Fig 12. Relative frequency (mean -- SEM) of NPY, VIP, TH, galanin 
(gal), and SP nerve fibers in islets from C57BL/6J mice after 12 Weeks' 
treatment with a control diet (R) or high-fat diet (IBi. The mean -+ 
SEM for semiquantitative estimation of the relative frequency is 
shown; n = 7 tO !0 for each bar. 
highly activated in insulin resistance and that insulin turnover is 
increased, causing increased insulin release. Thus, it seems that 
long-stancfing insulin resistance for 8 to 12 weeks induces 
increased insulin gen e expression and increased B-cell sensitiv- 
ity to cholinergic activation together with impairment of 
gluc0se-stimulated insulin secretion. 
We found that following long'term insulin resistance of 12 
weeks, the insulin secretory response to glucose failed. This 
phenomenon may represent an early decompensation in islet 
function that might be a mechanism of importance i n diabetes 
path0genesis. Several explanations may be offered for the 
failing glucose-stimulated insulin secretion following treatment 
with a high-fat diet for several weeks. One possible xplanation 
is increased sympathoadrenal activity, which has been demon- 
strated in C57BL/6J mice given a high-fat diet showing 
increased glycemic responses to slress and epinephrine. 11,12 
Such a n increased sympathoadrenal activation would diminish 
insulin secretionY Another explanation is that the hyperglyce- 
mia, although slight but chronic, impairs islet function due to a 
long-standing B-cell glucose toxicity. 3°,31 However, this expla: 
nation is unlikely in these mice, since it previously has been 
demonstrated that a 7-day exposure to high glucose (28 and 56 
mmo1/L) did not cause any deterioration i islets isolated from 
C57BL/6J mice. 32 A third explanation is that the hyperlipid- 
emia, particularly the increased circulating levels of triglycer- 
ides and FFAs, that were evident in our mice, caused the 
deteriorated glucose-stimulated insulin secretion. In fact, it has 
previously been demonstrated that lipid infusion in rats inhibits 
glucose-stimulated insulin secretion) 3 and several groups have 
shown that islets incubated uring a long period with fatty acids 
exhibit inhibited glucose-stimulated insulin secretion. 34-36 How- 
ever, in the present study, this explanation was not explored in 
detail, since plasma lipid levels were determined only after 6 
weeks on the high-fat diet. Finally, a fourth explanation is that a 
high-fat diet induced impaired signaling mechanisms crucial to 
insulin secretion, in analogy with recent findings in the Zucker 
diabetic fattY rat .  37 However, the exact nature of the mechanism 
of the impaired glucose-stimulated insulin secretion in C57BL/6J 
mice on a high:fat diet remains m be clarified. It should be 
emphasized that we found the impaired insulin secretion under 
both in vitro and in vivo conditions, which indicates that 
long-term alterations of islet function rather than in vivo 
conditions determine the failing insulinotropic action of glu- 
cose. 
As demonstrated byour immunocytochemical analysis of the 
islets, the pattern of islet innervation was not altered by a 
high-fat diet. We studied the innervation pattern of islets with 
regard to TH. NPY, and galanin, which are associated with 
sympathetic adrenergic nerves, with VIR which is associated 
with parasympathetic cholinergic nerves, and with SR which is 
associated with sensory nervesY ,25 However. all these different 
fibers in the islets disp!ayed a similar distribution pattern and 
relative frequency in mice given the high-fat and control diets. 
This suggests that changes in insulin secretion after treatment 
with the high-fat diet are not related to an altered pattern of 
innervation from a morphologic point of view. which does not 
exclude functional alterations in the neural regulation of islet 
hormone secretion. 
In conclusion, we have demonstrated that treatment of the 
C57BL/6J strain of mice with a high-fat diet induces insulin 
resistance already after 1 week. as shown by marked hyperinsu- 
|inemia nd slight hyperglycemia. Furthermore. after 12 weeks 
of treatment, glucose-induced insulin secretion is impaired both 
in VlVO and in vitro, whereas carbachol-stimulated insulin 
secretion is potentiated. Moreover. the insulin gene is upregu- 
lated, but the islet size is not altered. Based on these results, we 
suggest that cholinergic supersensitivity and an increased B-cell 
turnover of insulin is a mechanism compensating for the 
peripheral insulin resistance with increased insulin secretion. 
whereas the falling glucose-stimulated insulin secretion repre- 
sents an early decompensation in islet function. 
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